Tenaya Therapeutics, Inc.
TNYA
$1.41
$0.1511.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -99.62M | -105.77M | -111.13M | -117.23M | -120.74M |
| Total Depreciation and Amortization | 8.94M | 8.97M | 8.47M | 8.56M | 8.64M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.51M | 19.57M | 20.09M | 22.20M | 21.73M |
| Change in Net Operating Assets | -4.78M | -7.73M | -7.93M | -7.57M | -7.47M |
| Cash from Operations | -76.95M | -84.95M | -90.50M | -94.04M | -97.84M |
| Capital Expenditure | -913.00K | -844.00K | -1.03M | -1.22M | -1.04M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 32.21M | 28.77M | 2.16M | -26.68M | 33.73M |
| Cash from Investing | 31.30M | 27.92M | 1.13M | -27.89M | 32.70M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.67M | 51.24M | 47.75M | 47.74M | 47.71M |
| Repurchase of Common Stock | -476.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 50.19M | 51.24M | 47.75M | 47.74M | 47.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.54M | -5.79M | -41.62M | -74.19M | -17.43M |